Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 470591Generated: October 26, 2026

Triethylamine → (4R,5S)-4-Methyl-3-(3-oxocyclohexanecarbonyl)-5-phenyloxazolidin-2-one

https://huagongshe.com/reaction/470591

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
ReactantPivaloyl chlorideHCID 62493—
ReactantLithium ChlorideHCID 433294—
Reactant(4R,5S)-(+)-4-Methyl-5-phenyl-2-oxazolidinoneHCID 2733812—
Reactant3-Oxocyclohexane-1-carboxylic acidHCID 2760252—
SolventTetrahydrofuranHCID 8028—
Product(4R,5S)-4-Methyl-3-(3-oxocyclohexanecarbonyl)-5-phenyloxazolidin-2-oneHCID 67510178—

Reaction Conditions

Temperature-20 °C

Reaction Steps

Racemic 3-oxocyclohexanecarboxylic acid (1.0 g, 7.03 mmol) was dissolved in THF (27.1 mL). To this solution was added triethylamine (1.9 mL, 13.5 mmol) followed by pivaloyl chloride (0.8 mL, 6.5 mmol) at −20° C. The resulting mixture was stirred at −20° C. for 1 h. After that, LiCl (0.252 g, 5.9 mmol) and (4R,5S)-4-methyl-5-phenyloxazolidin-2-one (0.959 g, 5.4 mmol) were added to the solution at −20° C. The reaction mixture was warmed to room temperature and stirred overnight, before the reaction was quenched with 0.2 N HCl. The THF was removed and the resulting mixture was partitioned by 0.2 N HCl and EtOAc. The organic layer was collected and washed with brine, dried (MgSO4) and concentrated. The resulting residue was purified by preparative HPLC (PHENOMENEX® Luna 5u C18 21.2×250 mm, isocratic elution with Method 1-MeOH/water containing 0.1% trifluoroacetic acid as defined above, 51% B over 30 min, 25 mL/min, 220 nM: the first peak (retention time=15.3 min) was (4R,5S)-4-methyl-3-((S)-3-oxocyclohexanecarbonyl)-5-phenyloxazolidin-2-one, Int-8A, (LCMS=302.0 [M+H]+), and the second peak (retention time=19.6 min) was (4R,5S)-4-methyl-3-((R)-3-oxocyclohexanecarbonyl)-5-phenyloxazolidin-2-one, Int-8B, LCMS=324.1 [M+Na]+ by comparison to the R-3-oxocyclohexanecarboxylic acid case (Aust. J. Chem., 34:2231 (1981)).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08629282B2
Source datasetuspto-grants-2014_01
ORD IDord-8b7ef1643e9843959f3159d9765c8f39
Source noteuspto-grants-2014_01